Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

C/EBPβ and nuclear factor of activated T cells differentially regulate Adamts-1 induction by stimuli associated with vascular remodeling

  • Oller, Jorge
  • Alfranca, Arántzazu
  • Méndez-Barbero, Nerea
  • Campanero, Miguel R.
  • Redondo, Juan Miguel
et al., Emerging evidence indicates that the metalloproteinase Adamts-1 plays a significant role in the pathophysiology of vessel remodeling, but little is known about the signaling pathways that control Adamts-1 expression. We show that vascular endothelial growth factor (VEGF), angiotensin-II, interleukin-1β, and tumor necrosis factor α, stimuli implicated in pathological vascular remodeling, increase Adamts-1 expression in endothelial and vascular smooth muscle cells. Analysis of the intracellular signaling pathways implicated in this process revealed that VEGF and angiotensin-II upregulate Adamts-1 expression via activation of differential signaling pathways that ultimately promote functional binding of the NFAT or C/EBPβ transcription factors, respectively, to the Adamts-1 promoter. Infusion of mice with angiotensin-II triggered phosphorylation and nuclear translocation of C/EBPβ proteins in aortic cells concomitantly with an increase in the expression of Adamts-1, further underscoring the importance of C/EBPβ signaling in angiotensin-II-induced upregulation of Adamts-1. Similarly, VEGF promoted NFAT activation and subsequent Adamts-1 induction in aortic wall in a calcineurin-dependent manner. Our results demonstrate that Adamts-1 upregulation by inducers of pathological vascular remodeling is mediated by specific signal transduction pathways involving NFAT or C/EBPβ transcription factors. Targeting of these pathways may prove useful in the treatment of vascular disease., This work was funded by the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad; SAF2012-34296 to J.M.R. and SAF2013-45258-P to M.R.C.), the Fundación La Marató TV3 (264/C/2012 to J.M.R.), the Spanish Ministry of Health (Ministerio de Sanidad y Consumo) Red de Investigación Cardiovascular (RIC) cofounded by FEDER (grants RD06/0042/0022 to J.M.R. and RD12/0042/0023 to A.G.A), and the Spanish Council for Scientific Research (CSIC; to M.R.C.). The Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) is supported by the Spanish Ministry of Economy and Competitiveness and the Pro-CNIC Foundation. J.O. is the holder of an FPI fellowship from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economía y Competitividad; BES 2010-034552). The cost of this publication has been paid in part by FEDER funds., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Excitotoxic inactivation of constitutive oxidative stress detoxification pathway in neurons can be rescued by PKD1

  • Pose-Utrilla, Julia
  • García-Guerra, Lucía
  • Puerto, Ana del
  • Martín, Abraham
  • Jurado-Arjona, Jerónimo
  • León-Reyes, Noelia S. de
  • Gamir-Morralla, Andrea
  • Sebastián-Serrano, Álvaro
  • García-Gallo, Mónica
  • Kremer, Leonor
  • Fielitz, Jens
  • Ireson, Christofer
  • Pérez-Álvarez, María José
  • Ferrer, Isidro
  • Hernández Álvarez, Félix
  • Ávila, Jesús
  • Lasa, Marina
  • Campanero, Miguel R.
  • Iglesias, Teresa
Excitotoxicity, a critical process in neurodegeneration, induces oxidative stress and neuronal death through mechanisms largely unknown. Since oxidative stress activates protein kinase D1 (PKD1) in tumor cells, we investigated the effect of excitotoxicity on neuronal PKD1 activity. Unexpectedly, we find that excitotoxicity provokes an early inactivation of PKD1 through a dephosphorylation-dependent mechanism mediated by protein phosphatase-1 (PP1) and dual specificity phosphatase-1 (DUSP1). This step turns off the IKK/NF-¿B/SOD2 antioxidant pathway. Neuronal PKD1 inactivation by pharmacological inhibition or lentiviral silencing in vitro, or by genetic inactivation in neurons in vivo, strongly enhances excitotoxic neuronal death. In contrast, expression of an active dephosphorylation-resistant PKD1 mutant potentiates the IKK/NF-¿B/SOD2 oxidative stress detoxification pathway and confers neuroprotection from in vitro and in vivo excitotoxicity. Our results indicate that PKD1 inactivation underlies excitotoxicity-induced neuronal death and suggest that PKD1 inactivation may be critical for the accumulation of oxidation-induced neuronal damage during aging and in neurodegenerative disorders., This work was supported by grants SAF2014-52737-P to T.I., SAF2013-45258-P to M.R. C., BFU2016-77885-P to F.H., SAF2014-54070-JIN to A.M. from Ministerio de Economía, Industria y Competitividad (Spain). It was also funded by P2010/BMD-2332 (Neurodegmodels) from Comunidad de Madrid to T.I., F.H. and J.A.) and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) to T.I., F.H., J.A., and I.F.). J.P.-U. is a recipient of a predoctoral contract from SAF2014-52737-P; L.G.-G. was funded by a contract from CIBERNED; A.G.-M. and A.S.S. were funded by contracts from CIBERNED cooperative projects 2013/07 and CIBERNED 2015-2/06, respectively. A.M., A.D.P. is a recipient of a Juan de la Cierva formación fellowship (Ministerio de Economía, Industria y Competitividad, Spain) associated to CIBERNED. J.J.-A. was funded by a predoctoral contract from CSIC (JAEPredoc program) and by CIBERNED. The cost of this publication has been paid in part by FEDER (European Funds for Regional Development) funds., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MAZ induces MYB expression during the exit from quiescence via the E2F site in the MYB promoter

  • Alvaro-Blanco, Josue
  • Urso, Katia
  • Chiodo, Yuri
  • Martín-Cortázar, Carla
  • Kourani, Omar
  • Gómez-del-Arco, Pablo
  • Rodríguez-Martínez, María
  • Calonge, Esther
  • Alcamí, José
  • Redondo, Juan Miguel
  • Iglesias, Teresa
  • Campanero, Miguel R.
Most E2F-binding sites repress transcription through the recruitment of Retinoblastoma (RB) family members until the end of the G1 cell-cycle phase. Although the MYB promoter contains an E2F-binding site, its transcription is activated shortly after the exit from quiescence, before RB family members inactivation, by unknown mechanisms. We had previously uncovered a nuclear factor distinct from E2F, Myb-sp, whose DNA-binding site overlapped the E2F element and had hypothesized that this factor might overcome the transcriptional repression of MYB by E2F-RB family members. We have purified Myb-sp and discovered that Myc-associated zinc finger proteins (MAZ) are major components. We show that various MAZ isoforms are present in Myb-sp and activate transcription via the MYB-E2F element. Moreover, while forced RB or p130 expression repressed the activity of a luciferase reporter driven by the MYB-E2F element, co-expression of MAZ proteins not only reverted repression, but also activated transcription. Finally, we show that MAZ binds the MYB promoter in vivo, that its binding site is critical for MYB transactivation, and that MAZ knockdown inhibits MYB expression during the exit from quiescence. Together, these data indicate that MAZ is essential to bypass MYB promoter repression by RB family members and to induce MYB expression., Spanish Ministerio de Economía, Industria y Competitividad [SAF2013–45258P to M.R.C., SAF2014–52737P to T.I.]; Instituto de Salud Carlos III [FIS PI12/0056 to J.A., CIBERNED to T.I.]; Spanish AIDS Research Network [RD16CIII/0002/0001 to J.A.]; FEDER funds (in part); Spanish National Center for Biotechnology [PT13/0001]. Funding for open access charge: Spanish Ministerio de Economía, Industria y Competitividad [SAF2013–45258P]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome

  • Oller, Jorge
  • Méndez-Barbero, Nerea
  • Ruiz, E. Josue
  • Villahoz, Silvia
  • Renard, Marjolijn
  • Canelas, Lizet I.
  • Briones, Ana M.
  • Alberca, Rut
  • Lozano-Vidal, Noelia
  • Hurlé, María A.
  • Milewicz, Dianna
  • Evangelista, Arturo
  • Salaices, Mercedes
  • Nistal, J. Francisco
  • Jiménez-Borreguero, Luis J.
  • Backer, Julie de
  • Campanero, Miguel R.
  • Redondo, Juan Miguel
Heritable thoracic aortic aneurysms and dissections (TAAD), including Marfan syndrome (MFS), currently lack a cure, and causative mutations have been identified for only a fraction of affected families. Here we identify the metalloproteinase ADAMTS1 and inducible nitric oxide synthase (NOS2) as therapeutic targets in individuals with TAAD. We show that Adamts1 is a major mediator of vascular homeostasis, given that genetic haploinsufficiency of Adamts1 in mice causes TAAD similar to MFS. Aortic nitric oxide and Nos2 levels were higher in Adamts1-deficient mice and in a mouse model of MFS (hereafter referred to as MFS mice), and Nos2 inactivation protected both types of mice from aortic pathology. Pharmacological inhibition of Nos2 rapidly reversed aortic dilation and medial degeneration in young Adamts1-deficient mice and in young or old MFS mice. Patients with MFS showed elevated NOS2 and decreased ADAMTS1 protein levels in the aorta. These findings uncover a possible causative role for the ADAMTS1-NOS2 axis in human TAAD and warrant evaluation of NOS2 inhibitors for therapy., CNIC is supported by the Spanish Ministerio de Economía, Industria y Competitividad (MINECO) and the Pro-CNIC Foundation and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). Support was also provided by grants from MINECO (grants SAF2013-45258P (M.R.C.), SAF2012-34296 (J.M.R.) and SAF2015-636333R (J.M.R.)), Fundacion La Marato (TV3 grants 20151331 (J.M.R.) and 20151330 (A.E.)), CSIC (M.R.C.), the CIBERCV of Ministerio de Sanidad (grant CB16/11/00264; J.M.R.) and the Red de Investigación Cardiovascular (RIC) of Ministerio de Sanidad (grants RD12/0042/0022 (J.M.R.), RD12/0042/0021 (A.E.), RD12/0042/0024 (M.S.), RD12/0042/0056 (J.L.J.-B.) and RD12/0042/0018 (J.F.N.)), and by a Marie Skłodowska-Curie fellowship (E.J.R.) and FPI fellowships BES 2010-034552 (J.O.) and SVP-2013-067777 (S.V.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth

  • Jiménez Pérez, Raúl
  • Martín-Cortázar, Carla
  • Kourani, Omar
  • Chiodo, Yuri
  • Córdoba, Raúl
  • Domínguez-Franjo, María Purificación
  • Redondo, Juan Miguel
  • Iglesias, Teresa
  • Campanero, Miguel R.
Tumor formation involves the acquisition of numerous capacities along the progression from a normal cell into a malignant cell, including limitless proliferation (immortalization) and anchorage-independent growth, a capacity that correlates extremely well with tumorigenesis. Great efforts have been made to uncover genes involved in tumor formation, but most genes identified participate in processes related to cell proliferation. Accordingly, therapies targeting these genes also affect the proliferation of normal cells. To identify potential targets for therapeutic intervention more specific to tumor cells, we looked for genes implicated in the acquisition of anchorage-independent growth and in vivo tumorigenesis capacity. A transcriptomic analysis identified CDCA7 as a candidate gene. Indeed, CDCA7 protein was upregulated in Burkitt's lymphoma cell lines and human tumor biopsy specimens relative to control cell lines and tissues, respectively. CDCA7 levels were also markedly elevated in numerous T and B-lymphoid tumor cell lines. While CDCA7 was not required for anchorage-dependent growth of normal fibroblasts or non-malignant lymphocytes, it was essential but not sufficient for anchorage-independent growth of lymphoid tumor cells and for lymphomagenesis. These data suggest that therapies aimed at inhibiting CDCA7 expression or function might significantly decrease the growth of lymphoid tumors., This work was supported by the Spanish Ministerio de Economía, Industria y Competitividad (MEIC) grants to MRC. (SAF2013-45258P and SAF2017-88881-R) and TIV. (SAF2014-52737P); and by Instituto de Salud Carlos III (CIBERNED) to TIV. The cost of this publication has been paid in part with FEDER funds. OK holds an FPI fellowship from MEIC (BES-2014-069236). The CNIC is supported by the Ministerio de Ciencia, Investigación y Universidades and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Conditional deletion of Rcan1 predisposes to hypertension-mediated intramural hematoma and subsequent aneurysm and aortic rupture

  • Villahoz, Silvia
  • Yunes-Leites, Paula Sofía
  • Méndez-Barbero, Nerea
  • Urso, Katia
  • Bonzón-Kulichenko, Elena
  • Ortega, Elena
  • Nistal, J. Francisco
  • Vázquez, Jesús
  • Offermanns, Stefan
  • Redondo, Juan Miguel
  • Campanero, Miguel R.
Aortic intramural hematoma (IMH) can evolve toward reabsorption, dissection or aneurysm. Hypertension is the most common predisposing factor in IMH and aneurysm patients, and the hypertensive mediator angiotensin-II induces both in mice. We have previously shown that constitutive deletion of Rcan1 isoforms prevents Angiotensin II-induced aneurysm in mice. Here we generate mice conditionally lacking each isoform or all isoforms in vascular smooth muscle cells, endothelial cells, or ubiquitously, to determine the contribution to aneurysm development of Rcan1 isoforms in vascular cells. Surprisingly, conditional Rcan1 deletion in either vascular cell-type induces a hypercontractile phenotype and aortic medial layer disorganization, predisposing to hypertension-mediated aortic rupture, IMH, and aneurysm. These processes are blocked by ROCK inhibition. We find that Rcan1 associates with GSK-3β, whose inhibition decreases myosin activation. Our results identify potential therapeutic targets for intervention in IMH and aneurysm and call for caution when interpreting phenotypes of constitutively and inducibly deficient mice., CNIC is supported by the Spanish Ministerio de Ciencia, Investigación y Universidades (MINECO) and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). Support was also provided by grants from MINECO (grants SAF2013- 45258P and SAF2017-88881R (M.R.C.), SAF2015-636333R (J.M.R.), PI15/01224 (J.F.N.), and BIO2015-67580-P (J.V.)), Comunidad de Madrid (grant AORTASANA-CM; B2017/ BMD-3676 (M.R.C. and J.M.R.)), CSIC (M.R.C.), Fundacion La Marato TV3 (grant 20151330 (J.M.R.)), The Marfan Foundation Faculty grant 2017 (J.M.R.), and the CIBERCV of Ministerio de Sanidad (grants CB16/11/00264 (J.M.R.) and CB16/11/00277 (J.V.)). S.V. and P.S.Y.-L. hold FPI fellowships SVP-2013-067777 and BES-2016-076637, respectively. The cost of this publication was paid in part with FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

CDCA7 regulates lymphoma cells migration and invasion through reorganization of the tubulin and the actomyosin cytoskeleton

  • Martín-Cortázar, Carla
  • Jiménez Pérez, Raúl
  • Chiodo, Yuri
  • Cayuela, María Luisa
  • Iglesias, Teresa
  • Campanero, Miguel R.
Resumen del trabajo presentado al 1st PhD Research Symposium in Health Sciences and Biomedicine, celebrado en la Universidad Autónoma de Madrid el 18 de mayo de 2018., This work was supported by the Spanish Ministerio de Economía, Industria y Competitividad (MINECO) grant to M.R.C. (SAF2013-45258P)., Peer reviewed